• 4462 Citations
  • 31 h-Index
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Valentina Guarneri is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 54 Similar Profiles
Breast Neoplasms Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Tumor-Infiltrating Lymphocytes Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Epirubicin Medicine & Life Sciences
Paclitaxel Medicine & Life Sciences
letrozole Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2001 2019

  • 4462 Citations
  • 31 h-Index
  • 117 Article
  • 7 Comment/debate
  • 5 Review article
  • 1 Chapter
2 Citations (Scopus)

Association of tumor-infiltrating lymphocytes with distant disease-free survival in the ShortHER randomized adjuvant trial for patients with early HER2+ breast cancer

Dieci, M. V., Conte, P., Bisagni, G., Brandes, A. A., Frassoldati, A., Cavanna, L., Musolino, A., Giotta, F., Rimanti, A., Garrone, O., Bertone, E., Cagossi, K., Sarti, S., Ferro, A., Piacentini, F., Maiorana, A., Orvieto, E., Sanders, M., Miglietta, F., Balduzzi, S. & 2 others, D'Amico, R. & Guarneri, V., Mar 1 2019, In : Annals of Oncology. 30, 3, p. 418-423 6 p.

Research output: Contribution to journalArticle

Open Access
Tumor-Infiltrating Lymphocytes
Disease-Free Survival
Breast Neoplasms
Confidence Intervals
Proportional Hazards Models
5 Citations (Scopus)

De-escalated therapy for HR+/HER2+ breast cancer patients with Ki67 response after 2-week letrozole: Results of the PerELISA neoadjuvant study

Guarneri, V., Dieci, M. V., Bisagni, G., Frassoldati, A., Bianchi, G. V., De Salvo, G. L., Orvieto, E., Urso, L., Pascual, T., Paré, L., Galván, P., Ambroggi, M., Giorgi, C. A., Moretti, G., Griguolo, G., Vicini, R., Prat, A. & Conte, P. F., Jun 1 2019, In : Annals of Oncology. 30, 6, p. 921-926 6 p., mdz055.

Research output: Contribution to journalArticle

Open Access
Breast Neoplasms
Drug Therapy
1 Citation (Scopus)

Escalation and de-escalation in HER2 positive early breast cancer

Dieci, M. V., Vernaci, G. & Guarneri, V., Jan 1 2019, In : Current Opinion in Oncology. 31, 1, p. 35-42 8 p.

Research output: Contribution to journalArticle

Breast Neoplasms
Drug Therapy

Immunotherapy in SCLC: Exceptional Clinical Benefit and Abscopal Pneumonitis After Radiotherapy

Bonanno, L., Pavan, A., Attili, I., Pasello, G. & Guarneri, V., Jan 2019, In : Journal of Thoracic Oncology. 14, 1, p. e5-e7

Research output: Contribution to journalArticle

Recommendations for the implementation of BRCA testing in ovarian cancer patients and their relatives

Gori, S., Barberis, M., Bella, M. A., Buttitta, F., Capoluongo, E., Carrera, P., Colombo, N., Cortesi, L., Genuardi, M., Gion, M., Guarneri, V., Incorvaia, L., La Verde, N., Lorusso, D., Marchetti, A., Marchetti, P., Normanno, N., Pasini, B., Pensabene, M., Pignata, S. & 9 others, Radice, P., Ricevuto, E., Sapino, A., Tagliaferri, P., Tassone, P., Trevisiol, C., Truini, M., Varesco, L. & Russo, A., Aug 1 2019, In : Critical Reviews in Oncology/Hematology. 140, p. 67-72 6 p.

Research output: Contribution to journalReview article

Open Access
Ovarian Neoplasms
BRCA1 Gene
Primary Prevention
Secondary Prevention